← Back to Search

Behavioural Intervention

Expressive Writing for Body Image Distress in Young Cancer Survivors

N/A
Waitlist Available
Led By Victoria Wytiaz, MD
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 15-39 years
History of one or more cancer diagnoses with all treatment (surgery, chemotherapy, radiation) completed ≥ 3 months before enrollment)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights

Study Summary

This trial tests a four-week in-home program to reduce body image distress & anxiety in 15-39 yr old cancer survivors. It could be life-changing.

Who is the study for?
This trial is for adolescent and young adult cancer survivors aged 15-39 who have finished cancer treatments at least 3 months prior. They must be experiencing body image distress but not planning any new cancer treatment or starting new therapies for body image issues during the study.Check my eligibility
What is being tested?
The trial tests a four-week in-home expressive writing program focused on body image (BI) to see if it can reduce BI distress and anxiety among participants. It's a pilot randomized-controlled trial, meaning some will use the writing program while others won't, to compare outcomes.See study design
What are the potential side effects?
Since this intervention involves expressive writing from home, there are no direct medical side effects like you'd expect with drugs or surgery. However, discussing sensitive topics could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 15 and 39 years old.
Select...
I finished all cancer treatments more than 3 months ago.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of in-home Body Image (BI) -focused expressive writing (EW) intervention for post-treatment adolescent and young adult (AYA) cancer survivors with BI distress (adherence)
Feasibility of in-home Body Image (BI) -focused expressive writing (EW) intervention for post-treatment adolescent and young adult (AYA) cancer survivors with BI distress (practicality)
Feasibility of in-home Body Image (BI) -focused expressive writing (EW) intervention for post-treatment adolescent and young adult (AYA) cancer survivors with BI distress (recruitment)
Secondary outcome measures
Acceptability of Intervention
Facilitators and barriers of the intervention

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Expressive Writing (EW)Experimental Treatment1 Intervention
four- week, in- home, Body Image (BI)- focused EW intervention
Group II: Attention ControlActive Control1 Intervention
four- week control writing program

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
292 Previous Clinical Trials
24,035 Total Patients Enrolled
Victoria Wytiaz, MDPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being actively sought for this clinical experiment?

"The information available on clinicaltrials.gov signals that this specific medical trial is no longer recruiting individuals, with the last update was made on September 13th 2023. However, there are presently 15 alternate trials looking for potential participants."

Answered by AI

Do seniors meet the eligibility requirements for participation in this clinical trial?

"This medical trial is seeking participants between 15 and 39 years of age."

Answered by AI

Is it possible to enlist in this research endeavor?

"To be eligible for this experiment, prospective participants must have an age between 15 and 39 and a diagnosis of cancer. This clinical trial is currently onboarding around 30 patients."

Answered by AI
~20 spots leftby Sep 2024